Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence

Summary

The investigators are imaging patients with prostate cancer using a new PET imaging agent (Ga-68-PSMA-11) in order to evaluate it's ability to detection prostate cancer in patients with biochemical recurrence after prostatectomy and radiation therapy.

Timeline

Start

2016-09-15

Primary completion

2017-09-21

Completion

2017-09-21

Drugs

Indications